Early research (Phase 1)Ended earlyNCT06171178What this trial is testingASP1012 in Adults With Solid TumorsWho this might be right forSolid Tumor Astellas Pharma Global Development, Inc. 15
Early research (Phase 1)Study completedNCT00911898What this trial is testingMM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive CancersWho this might be right forHer2 Amplified Solid TumorsMetastatic Breast Cancer Merrimack Pharmaceuticals 20
Not applicableAvailableNCT06948955What this trial is testingExpanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal TumorsWho this might be right forGastrointestinal Neoplasms, Gastrointestinal Stromal Tumors Cogent Biosciences, Inc.
Early research (Phase 1)Study completedNCT00499811What this trial is testingVorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver DysfunctionWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+60 more National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT01300533What this trial is testingBIND-014 Given to Patients With Advanced or Metastatic CancerWho this might be right forMetastatic CancerCancerSolid Tumors BIND Therapeutics 58
Early research (Phase 1)Study completedNCT00089271What this trial is testing17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomasWho this might be right forAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+47 more National Cancer Institute (NCI) 60
Early research (Phase 1)Active Not RecruitingNCT03435952What this trial is testingPembrolizumab With Intratumoral Injection of Clostridium Novyi-NTWho this might be right forMalignant Neoplasm of BreastMalignant Neoplasms of Digestive OrgansMalignant Neoplasms of Eye Brain and Other Parts of Central Nervous System+9 more M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT03345485What this trial is testingStudy of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.Who this might be right forSmall Cell Lung CancerSoft Tissue SarcomaTriple-negative Breast Cancer+2 more Mundipharma Research Limited 71
Early research (Phase 1)Study completedNCT03219268What this trial is testingMGD013 in Patients With Unresectable or Metastatic NeoplasmsWho this might be right forAdvanced Solid TumorsHematologic NeoplasmsOvarian Cancer+7 more MacroGenics 277
Testing effectiveness (Phase 2)Study completedNCT00365768What this trial is testingGlutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid TumorsWho this might be right forKidney CancerLeukemiaLymphoma+3 more Columbia University 56
Early research (Phase 1)Study completedNCT01353625What this trial is testingStudy to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.Who this might be right forGlioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more Celgene 118
Early research (Phase 1)Study completedNCT00929903What this trial is testingPazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to TreatmentWho this might be right forChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Embryonal TumorChildhood Central Nervous System Germ Cell Tumor+10 more National Cancer Institute (NCI) 55
Early research (Phase 1)Study completedNCT06108479What this trial is testingStudy of DF6215 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, AdultSolid Tumor Cancer Dragonfly Therapeutics 35
Early research (Phase 1)Looking for participantsNCT05746897What this trial is testingA First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid TumorsWho this might be right forOvarian CancerMelanomaTriple Negative Breast Cancer+1 more Hefei TG ImmunoPharma Co., Ltd. 38
Early research (Phase 1)Study completedNCT00169000What this trial is testingSafety Study of a New Schedule of Capecitabine and Docetaxel to Treat CancersWho this might be right forMetastatic Breast Cancer Dartmouth-Hitchcock Medical Center 12
Early research (Phase 1)Looking for participantsNCT07137416What this trial is testingTesting the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Carcinoma+13 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Looking for participantsNCT05877430What this trial is testingSafety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic CancerWho this might be right forNSCLCHNSCCMelanoma+3 more CJ Bioscience, Inc. 160
Early research (Phase 1)Study completedNCT02222922What this trial is testingPF-06647020 For Adult Patients With Advanced Solid TumorsWho this might be right forNeoplasms Pfizer 138
Early research (Phase 1)Looking for participantsNCT06586957What this trial is testingA Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more NiKang Therapeutics, Inc. 150
Testing effectiveness (Phase 2)UnknownNCT03961698What this trial is testingEvaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell CarcinomaWho this might be right forBreast CancerRenal Cell Carcinoma Infinity Pharmaceuticals, Inc. 91